Bill Search

  • Introduced
    Mar 06, 2023
  • Passed House
  • Passed Senate
  • Signed into Law
HB 1509
Florida House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Prescription Drugs; Requires drug manufacturers to notify DBPR of reportable drug price increases; prohibits manufacturers from claiming public records exemption for trade secrets for information provided in forms or reports; requires DFS to designate employee as primary contact on issues relating to PBMs; provides penalty for persons who do not hold certificate of authority to act as administrator; requires PBMs to identify ownership affiliations to office; provides requirements for contracts between PBM & participating pharmacy; provides for biennial examinations of PBMs. APPROPRIATION: $1,127,525
Last Action See all actions
House • May 01, 2023: Laid on Table; companion bill(s) passed, see CS/CS/SB 1550 (Ch. 2023-29), CS/SB 1552 (Ch. 2023-30)
Latest Bill Text See all bill texts

Summary/Bill Text

Comments on HB 1509

Tweets

Whip Lists

Sponsors
Actions
  • May 01, 2023 | House
    • Laid on Table; companion bill(s) passed, see CS/CS/SB 1550 (Ch. 2023-29), CS/SB 1552 (Ch. 2023-30)
  • Apr 25, 2023 | House
    • Laid on Table under Rule 7.18(a)
    • CS Filed
    • Bill referred to House Calendar
    • 1st Reading (Committee Substitute 3)
    • Added to Second Reading Calendar
  • Apr 24, 2023 | House
    • Favorable with CS by Health & Human Services Committee
    • 1st Reading (Committee Substitute 2)
    • Reported out of Health & Human Services Committee
  • Apr 23, 2023 | House
    • Added to Health & Human Services Committee agenda
  • Apr 22, 2023 | House
    • Referred to Health & Human Services Committee
    • Now in Health & Human Services Committee
  • Apr 21, 2023 | House
    • Favorable with CS by Appropriations Committee
    • Reported out of Appropriations Committee
    • Laid on Table under Rule 7.18(a)
    • CS Filed
  • Apr 20, 2023 | House
    • Added to Appropriations Committee agenda
  • Apr 04, 2023 | House
    • Referred to Appropriations Committee
    • Referred to Health & Human Services Committee
    • Now in Appropriations Committee
  • Apr 03, 2023 | House
    • Reported out of Healthcare Regulation Subcommittee
    • Laid on Table under Rule 7.18(a)
    • CS Filed
    • 1st Reading (Committee Substitute 1)
  • Mar 28, 2023 | House
    • Favorable with CS by Healthcare Regulation Subcommittee
  • Mar 24, 2023 | House
    • Added to Healthcare Regulation Subcommittee agenda
  • Mar 09, 2023 | House
    • Referred to Healthcare Regulation Subcommittee
    • Referred to Appropriations Committee
    • Referred to Health & Human Services Committee
    • Now in Healthcare Regulation Subcommittee
  • Mar 07, 2023 | House
    • 1st Reading (Original Filed Version)
  • Mar 06, 2023 | House
    • Filed